Sodium Bicarbonate

碳酸氢钠

Report date: 2026/05/02 20:00:18
NME

Base Information

Drug NameSodium Bicarbonate
Drug Alias NameBicanormAlka-MisrE500
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsRejection of renal transplantationContrast-induced nephropathySolid tumours +[23] 
Global Approved IndicationshyperchlorhydriaAcidosis
Approved Indications in ChinahyperchlorhydriaAcidosis
Original Approved Country/TerritoryJapan
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesUganda +[12] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesSioe Pharmaceutical Co LtdUniversity Of Colorado DenverEmory University +[7] 
Inactive CompaniesInstituto Nacional De Cardiologia Ignacio ChavezUtah State UniversityAzidus Brasil +[18] 
Active IndicationshyperchlorhydriaCognitive DysfunctionAcidosis +[7] 
Inactive IndicationsRejection of renal transplantationContrast-induced nephropathySolid tumours +[16] 

Other Information

ATC CodeB05CB04B05XA02
Related LinksWikipediaDrugBankKEGG